1073 related articles for article (PubMed ID: 28718050)
41. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
42. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
[No Abstract] [Full Text] [Related]
43. Microneedle patches for vaccination in developing countries.
Arya J; Prausnitz MR
J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
[TBL] [Abstract][Full Text] [Related]
44. Design, characterization, and modeling of a chitosan microneedle patch for transdermal delivery of meloxicam as a pain management strategy for use in cattle.
Castilla-Casadiego DA; Carlton H; Gonzalez-Nino D; Miranda-Muñoz KA; Daneshpour R; Huitink D; Prinz G; Powell J; Greenlee L; Almodovar J
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111544. PubMed ID: 33255096
[TBL] [Abstract][Full Text] [Related]
45. Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing.
Rajabi M; Roxhed N; Shafagh RZ; Haraldson T; Fischer AC; Wijngaart WV; Stemme G; Niklaus F
PLoS One; 2016; 11(12):e0166330. PubMed ID: 27935976
[TBL] [Abstract][Full Text] [Related]
46. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
Chen MC; Huang SF; Lai KY; Ling MH
Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
[TBL] [Abstract][Full Text] [Related]
47. Enhanced anti-tumor immunotherapy by dissolving microneedle patch loaded ovalbumin.
Lee SJ; Lee HS; Hwang YH; Kim JJ; Kang KY; Kim SJ; Kim HK; Kim JD; Jeong DH; Paik MJ; Yee ST
PLoS One; 2019; 14(8):e0220382. PubMed ID: 31386690
[TBL] [Abstract][Full Text] [Related]
48. Biodegradable microneedle patch for delivery of meloxicam for managing pain in cattle.
Castilla-Casadiego DA; Miranda-Muñoz KA; Roberts JL; Crowell AD; Gonzalez-Nino D; Choudhury D; Aparicio-Solis FO; Servoss SL; Rosales AM; Prinz G; Zou M; Zhang Y; Coetzee JF; Greenlee LF; Powell J; Almodovar J
PLoS One; 2022; 17(8):e0272169. PubMed ID: 35917312
[TBL] [Abstract][Full Text] [Related]
49. Dissolving microneedle vaccine delivery systems.
Park K
J Control Release; 2016 Mar; 225():314. PubMed ID: 26919809
[No Abstract] [Full Text] [Related]
50. [Development of transcutaneous vaccination system for infectious disease countermeasure].
Matsuo K
Yakugaku Zasshi; 2012; 132(12):1443-50. PubMed ID: 23208052
[TBL] [Abstract][Full Text] [Related]
51. Dissolving microneedle patch for transdermal delivery of human growth hormone.
Lee JW; Choi SO; Felner EI; Prausnitz MR
Small; 2011 Feb; 7(4):531-9. PubMed ID: 21360810
[TBL] [Abstract][Full Text] [Related]
52. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects.
Arya J; Henry S; Kalluri H; McAllister DV; Pewin WP; Prausnitz MR
Biomaterials; 2017 Jun; 128():1-7. PubMed ID: 28285193
[TBL] [Abstract][Full Text] [Related]
53. Adenosine-loaded dissolving microneedle patches to improve skin wrinkles, dermal density, elasticity and hydration.
Kang G; Tu TNT; Kim S; Yang H; Jang M; Jo D; Ryu J; Baek J; Jung H
Int J Cosmet Sci; 2018 Apr; 40(2):199-206. PubMed ID: 29574973
[TBL] [Abstract][Full Text] [Related]
54. A key role by polymers in microneedle technology: a new era.
Rajput A; Kulkarni M; Deshmukh P; Pingale P; Garkal A; Gandhi S; Butani S
Drug Dev Ind Pharm; 2021 Nov; 47(11):1713-1732. PubMed ID: 35332822
[TBL] [Abstract][Full Text] [Related]
55. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.
Zhao JH; Zhang QB; Liu B; Piao XH; Yan YL; Hu XG; Zhou K; Zhang YT; Feng NP
Int J Nanomedicine; 2017; 12():4763-4772. PubMed ID: 28740383
[TBL] [Abstract][Full Text] [Related]
56. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
57. The Troy Microneedle: A Rapidly Separating, Dissolving Microneedle Formed by Cyclic Contact and Drying on the Pillar (CCDP).
Kim M; Yang H; Kim S; Lee C; Jung H
PLoS One; 2015; 10(8):e0136513. PubMed ID: 26308945
[TBL] [Abstract][Full Text] [Related]
58. Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs.
Chu LY; Choi SO; Prausnitz MR
J Pharm Sci; 2010 Oct; 99(10):4228-38. PubMed ID: 20737630
[TBL] [Abstract][Full Text] [Related]
59. Microneedle patch based on dissolving, detachable microneedle technology for improved skin quality of the periorbital region. Part 2: Clinical Evaluation.
Zvezdin V; Kasatkina T; Kasatkin I; Gavrilova M; Kazakova O
Int J Cosmet Sci; 2020 Oct; 42(5):429-435. PubMed ID: 32485024
[TBL] [Abstract][Full Text] [Related]
60. Current trends in polymer microneedle for transdermal drug delivery.
Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
